Table 2 Baseline Characteristics in Male Versus Female Patients
Characteristic | Male (n = 118) | Female (n = 84) |
|---|---|---|
Mean age, years (SD) | 64.0 (12.7) | 69.5 (11.3) |
Baseline occlusion type, n (%) | ||
BRVO/HRVO | 59 (50.0) | 56 (66.7) |
CRVO | 59 (50.0) | 28 (33.3) |
Mean BCVA, ETDRS letters (SD) | 52.2 (14.0) | 55.0 (11.6) |
Patients with 20/200 or worse vision, n (%) | 22 (18.6) | 8 (9.5) |
Mean CST, μm (SD) | 539.0 (177.5) | 508.6 (138.3) |
Mean time since diagnosis of RVO, months (SD) | 1.7 (2.1) | 1.7 (1.7) |
Prior therapies, n (%) | ||
Intravitreal steroids | 7 (5.9) | 2 (2.4) |
Laser photocoagulation | 1 (0.8) | 1 (1.2) |
Comorbidities, n (%) | ||
Open-angle glaucoma | 10 (8.5) | 7 (8.3) |
Hypertension | 70 (59.3) | 61 (72.6) |
Angina | 4 (3.4) | 3 (3.6) |
Congestive heart failure | 2 (1.7) | 4 (4.8) |
Diabetes mellitus | 18 (15.3) | 13 (15.5) |